Qingdao Baheal Medical INC.: Announcement on Revision of Certain Clauses of the Acquisition Agreement of Shanghai Baiyang Pharmaceutical Co., Ltd., Qingdao Baiyang Investment Group Co., Ltd., Qingdao Baiyang Yiren Investment Management Co., Ltd. and Beijing Baiyang Kanghe Technology Co., Ltd.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

百洋医药：关于修订《关于上海百洋制药股份有限公司、青岛百洋投资集团有限公司、青岛百洋伊仁投资管理有限公司及北京百洋康合科技有限公司之收购协议》部分条款的公告

Qingdao Baheal Medical INC.: Announcement on Revision of Certain Clauses of the Acquisition Agreement of Shanghai Baiyang Pharmaceutical Co., Ltd., Qingdao Baiyang Investment Group Co., Ltd., Qingdao Baiyang Yiren Investment Management Co., Ltd. and Beijing Baiyang Kanghe Technology Co., Ltd.

Risk Disclaimer

Statement